Guillaume Beranger

INSERM U1065

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Delphine Debayle

Institute of Pharmacology

FRANCE

View details

Yann CHELI

INSERM

FRANCE

View details

Robert BALLOTTI

Head, team1

INSERM

FRANCE

View details

Jérémy Raymond

University of Oxford

UNITED KINGDOM

View details

Meri K. Tulic

Université Côte d'Azur

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guillaume Beranger

Research Interests

Explore related searches

Contact this professor

Articles (8)

CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3

ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma

Dual covalent inhibition of PKM and IMPDH targets metabolism in cutaneous metastatic melanoma.

Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease

Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.

FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.

Collaborators (5)

Delphine Debayle

Yann CHELI

Robert BALLOTTI

Jérémy Raymond

Meri K. Tulic

Make your next move.